SE9403905D0 - New formulations - Google Patents

New formulations

Info

Publication number
SE9403905D0
SE9403905D0 SE9403905A SE9403905A SE9403905D0 SE 9403905 D0 SE9403905 D0 SE 9403905D0 SE 9403905 A SE9403905 A SE 9403905A SE 9403905 A SE9403905 A SE 9403905A SE 9403905 D0 SE9403905 D0 SE 9403905D0
Authority
SE
Sweden
Prior art keywords
new formulations
chitosan polymer
active agent
therapeutic active
formulation
Prior art date
Application number
SE9403905A
Other languages
Swedish (sv)
Inventor
Per Artursson
N G M Schipper
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9403905A priority Critical patent/SE9403905D0/en
Publication of SE9403905D0 publication Critical patent/SE9403905D0/en
Priority to CA 2203632 priority patent/CA2203632A1/en
Priority to EP95937278A priority patent/EP0792330A1/en
Priority to JP8517163A priority patent/JPH10509207A/en
Priority to PCT/SE1995/001342 priority patent/WO1996020730A1/en
Priority to AU39433/95A priority patent/AU710769B2/en
Priority to IS4469A priority patent/IS4469A/en
Priority to NO972172A priority patent/NO972172D0/en
Priority to FI972056A priority patent/FI972056A/en

Links

Abstract

The present invention relates to a pharmaceutical formulation comprising a chitosan polymer having a degree of acetylation of between 20 % and 45 % and a molecular weight of above 75,000, and a therapeutic active agent, a chitosan polymer for preparing said formulation, and the use of said chitosan polymer and a method of enhancing the absorption of a therapeutic active agent.
SE9403905A 1994-11-14 1994-11-14 New formulations SE9403905D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9403905A SE9403905D0 (en) 1994-11-14 1994-11-14 New formulations
CA 2203632 CA2203632A1 (en) 1994-11-14 1995-11-13 A chitosan polymer having a specific degree of acetylation
EP95937278A EP0792330A1 (en) 1994-11-14 1995-11-13 A chitosan polymer having a specific degree of acetylation
JP8517163A JPH10509207A (en) 1994-11-14 1995-11-13 Chitosan polymer with specific degree of acetylation
PCT/SE1995/001342 WO1996020730A1 (en) 1994-11-14 1995-11-13 A chitosan polymer having a specific degree of acetylation
AU39433/95A AU710769B2 (en) 1994-11-14 1995-11-13 A chitosan polymer having a specific degree of acetylation
IS4469A IS4469A (en) 1994-11-14 1997-04-22 Cytosan polymer with a certain acetylation ratio
NO972172A NO972172D0 (en) 1994-11-14 1997-05-12 Chitosan polymer with a specific degree of acetylation
FI972056A FI972056A (en) 1994-11-14 1997-05-14 Chitosan polymer with a specific degree of acetylation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9403905A SE9403905D0 (en) 1994-11-14 1994-11-14 New formulations

Publications (1)

Publication Number Publication Date
SE9403905D0 true SE9403905D0 (en) 1994-11-14

Family

ID=20395954

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9403905A SE9403905D0 (en) 1994-11-14 1994-11-14 New formulations

Country Status (9)

Country Link
EP (1) EP0792330A1 (en)
JP (1) JPH10509207A (en)
AU (1) AU710769B2 (en)
CA (1) CA2203632A1 (en)
FI (1) FI972056A (en)
IS (1) IS4469A (en)
NO (1) NO972172D0 (en)
SE (1) SE9403905D0 (en)
WO (1) WO1996020730A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020018732A1 (en) * 2000-04-21 2002-02-14 Hung William M. Preserving compositions containing chitosan and processes for making water soluble O-acetylated chitosan and chitosan
US6716970B2 (en) 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
GB0315632D0 (en) 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
US7125967B2 (en) 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
WO2007002345A2 (en) * 2005-06-21 2007-01-04 Bausch & Lomb Incorporated Method for improving water solubility of chitosan
FR3016882A1 (en) 2014-01-30 2015-07-31 Sofradim Production PROCESS FOR THE PREPARATION OF HIGH-DEGREE ACETYLATION CHITOSAN
EP3034612A1 (en) * 2014-12-16 2016-06-22 Greenaltech, S.L. Chitin and chitosan producing methods
US10646579B2 (en) 2015-11-04 2020-05-12 Tme Therapeutics Inc. Complex comprising RNAi molecule and N-acetylated chitosan
WO2024054707A2 (en) 2022-09-08 2024-03-14 Luna Labs Usa, Llc Layer-by-layer delivery of active agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873092A (en) * 1987-05-21 1989-10-10 Murata Kikai Kabushiki Kaisha Slow-releasing preparation
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions

Also Published As

Publication number Publication date
AU3943395A (en) 1996-07-24
WO1996020730A1 (en) 1996-07-11
CA2203632A1 (en) 1996-07-11
FI972056A0 (en) 1997-05-14
AU710769B2 (en) 1999-09-30
IS4469A (en) 1997-04-22
JPH10509207A (en) 1998-09-08
NO972172L (en) 1997-05-12
NO972172D0 (en) 1997-05-12
EP0792330A1 (en) 1997-09-03
FI972056A (en) 1997-05-14

Similar Documents

Publication Publication Date Title
ES2118834T3 (en) IMPROVED SKIN PENETRATION SYSTEM FOR THE IMPROVED TOPICAL ADMINISTRATION OF PHARMACES.
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
ID28003A (en) ADAMANTANA'S DEMONS
UA26455C2 (en) MEDICINAL PRODUCT IN THE FORM OF TABLETS WITH SLOW RELEASE OF THE ACTIVE INGREDIENT
NO20002741L (en) Vaccine compositions comprising chitosan, for mucosal administration
NO971192L (en) Methods for delivering materials into the skin and compositions used
MY130477A (en) Pharmaceutical compositions for the treatmen of mucositis, stomatitis and behcet,s syndrome
CA2274074A1 (en) Novel compounds with analgesic effect
CA2293470A1 (en) Benzimidazole derivatives
IL112572A0 (en) Dexanabinol derivatives and their use as nmda blocking pharmaceutical compositions
HUP9602498A2 (en) Pharmaceutical compositions of antimicrobial activity
ATE67662T1 (en) TOPICAL ANTIBIOTIC COMPOSITION FOR THE TREATMENT OF THE MUSCLES.
SE9403905D0 (en) New formulations
EE03663B1 (en) Method of preventing breast cancer, pharmaceutical preparation and product, and use of the active ingredient
DE69935526D1 (en) SUPRAMOLECULAR COMPLEX-CONTAINING MEDICAMENTS
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
BR9404225A (en) Formulation of active substance, application, compositions, drugs and process for the preparation of formulations
FR2794976B1 (en) PHARMACEUTICAL COMPOSITIONS WITH HEALING OR ANTI-COMPLEMENTARY ACTION COMPRISING A DEXTRANE DERIVATIVE
EP0744176A3 (en) Methods for inhibiting bone loss
BR9710629A (en) Pharmaceutical composition Process for its preparation Compound for use as a therapeutic agent and use and use of a compound
IT1216556B (en) PEPTIDAL DERIVATIVES OF 3_AMINODIIDROTIOFEN_2_ONE, THEIR PREPARATION AND THERAPEUTIC USE.
KR970032876A (en) Pharmaceutical composition for treating liver disease
ITPD920102A0 (en) PHARMACEUTICAL COMPOSITION USEFUL FOR TREATING GASTROENTERIC DISEASES, WOUNDS AND BURNS AND AS A HEMOSTATIC AGENT
FR2702768B1 (en) New mono-amides of Carpain, their preparation and their use as medicaments.
IT8620713A0 (en) NEW DERIVATIVES WITH THERAPEUTIC ACTIVITY, PROCEDURE FOR THEIR PREPATION AND RELATED PHARMACEUTICAL COMPOSITIONS.